These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload. Greenway A, Ware RE, Thornburg CD. Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640 [Abstract] [Full Text] [Related]
25. Plasma levels of aminothiols, nitrite, nitrate, and malondialdehyde in myelodysplastic syndromes in the context of clinical outcomes and as a consequence of iron overload. Pimková K, Chrastinová L, Suttnar J, Štikarová J, Kotlín R, Čermák J, Dyr JE. Oxid Med Cell Longev; 2014 Apr; 2014():416028. PubMed ID: 24669287 [Abstract] [Full Text] [Related]
26. Hepatopulmonary syndrome associated with iron overload in sickle cell anaemia. Grinnan D, Herlihy A, Smith WR. Eur Respir J; 2012 Jul; 40(1):275-6. PubMed ID: 22753840 [No Abstract] [Full Text] [Related]
38. Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload. Aygun B, Mortier NA, Kesler K, Lockhart A, Schultz WH, Cohen AR, Alvarez O, Rogers ZR, Kwiatkowski JL, Miller ST, Sylvestre P, Iyer R, Lane PA, Ware RE, Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) Trial Investigators. Br J Haematol; 2015 Apr; 169(2):262-6. PubMed ID: 25612463 [Abstract] [Full Text] [Related]